Blue Trust Inc
TLX icon

Blue Trust Inc’s Telix Pharmaceuticals TLX Stock Holding History

Blue Trust Inc’s Portfolio TLX Stock Details TLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-742
Closed -$8.56K – 2817
2026
Q2 		$8.56K Hold
742
– – ﹤0.01% 1901
2026
Q1 		$7.1K Sell
742
-2,344
-76% -$17.9K ﹤0.01% 1914
2025
Q4 		$23.1K Buy
3,086
+1,880
+156% +$18.1K ﹤0.01% 1637
2025
Q3 		$11.5K Buy
+1,206
New +$14.8K ﹤0.01% 1831

Other funds holding TLX

Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Aubrey Capital Management
Aubrey Capital Management Edinburgh, United Kingdom $115M AUM 51.42% 1-Year Est. Return
WoodTrust Financial
WoodTrust Financial Wisconsin Rapids, Wisconsin $825M AUM 20.13% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Aspect Partners
Aspect Partners Fairfax, Virginia $264M AUM 15.76% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Physician Wealth Advisors
Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return
Root Financial Partners
Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

Blue Trust Inc's TLX Position: Q3 2026 in Review

Blue Trust Inc sold out of Telix Pharmaceuticals (TLX) in Q3 2026, closing a stake of 742 shares — an estimated $8.56K sold.

Blue Trust Inc first reported a position in TLX in Q3 2025 and held it in 4 quarters. The position peaked at $23.1K in Q4 2025. 10 funds tracked by Wall St. Rank hold TLX as of Q3 2026.

  • Blue Trust Inc reported no remaining Telix Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Blue Trust Inc sold 742 Telix Pharmaceuticals shares in Q3 2026, an estimated $8.56K.
  • Blue Trust Inc first reported a position in Telix Pharmaceuticals in Q3 2025 and held it in 4 quarters.
  • Blue Trust Inc's Telix Pharmaceuticals position peaked at $23.1K in Q4 2025.
  • 10 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q3 2026.

Based on Blue Trust Inc's 13F filing for Q3 2026, filed 15 Oct 2026.